Showing 3351-3360 of 5839 results for "".
- First-Ever Molecular Study Shows African American Skin Reacts Differently to ADhttps://practicaldermatology.com/news/first-ever-molecular-study-shows-african-american-skin-reacts-differently-to-ad/2457612/African Americans are known to have greater treatment challenges with atopic dermatitis than European Americans and require higher doses of some medications to get relief, and now a new study suggests that differences in the molecular profile of their skin may be the reason. About 19 perc
- Business News: Candela Acquires Ellipsehttps://practicaldermatology.com/news/business-news-candela-acquires-ellipse/2457616/Candela Corporation has acquired Ellipse, a Danish medical device company that manufactures and markets Intense Pulsed Light (IPL) and laser-based platforms for a wide variety of medical and aesthetic skin treatments. Financial terms of the agreement were not disclosed. “The
- Melanoma Research Alliance Seeks Proposals, Funding Availablehttps://practicaldermatology.com/news/melanoma-research-alliance-seeks-proposals-funding-available/2457643/The Melanoma Research Alliance (MRA) is sol
- Frequent BCC Linked to Other Cancershttps://practicaldermatology.com/news/frequent-bcc-linked-to-other-cancers/2457651/Basal cell carcinoma may increase risk for the development of other cancers, including blood, breast, colon and prostate cancers, according to a preliminary study by researchers at the Stanford University School of Medicine. "We discovered that people who develop six or more basal ce
- New Data from DermTech Presented at International Investigational Dermatology Meetinghttps://practicaldermatology.com/news/new-data-from-dermtech-presented-at-international-investigational-dermatology-meeting/2457724/DermTech, Inc., has announced the publication of two clinical study abstracts at the 2018 International Investigational Dermatology meeting
- Skin Cancer Survey Spotlights Frustration with Perceptions of "Less Serious" Conditionhttps://practicaldermatology.com/news/skin-cancer-survey-spotlights-frustration-with-perceptions-of-less-serious-condition/2457743/People living with skin cancer struggle with perceptions that their condition is less serious than other types of cancer despite significant physical and emotional impact, according to Skin Cancer In America 2018, a national survey by Health Union, LLC of people diagnosed with the condition.
- Physician Assistant Groups Respond to JAMA Dermatology Study: "Fundamentally Flawed"https://practicaldermatology.com/news/physician-assistant-groups-respond-to-jama-dermatology-study-fundamentally-flawed/2457798/The American Academy of PAs (AAPA) and the Society of Dermatology PAs (SDPA) have issued a statemen
- GlobalData: Promising Future Forecasted for Dupixenthttps://practicaldermatology.com/news/globaldata-promising-future-forecasted-for-dupixent/2457917/Regeneron Pharmaceuticals and Sanofi Genzyme’s Dupixent is currently the most successful biologic treatment for moderate-to-severe atopic dermatitis on the market, according to
- New from Nerium: Prolistic Probiotic Productshttps://practicaldermatology.com/news/new-from-nerium-prolistic-probiotic-products/2457921/Nerium International is rolling out Prolistic™ Pre & Probiotic Plus Vitamins powder packets and Prolistic™Skin-Balancing Lotion with Probiotic Technology. The new Prolistic Pre & Probiotic Plus Vitamins powder
- Promius Pharma Employees Fundraise for Hurricane Victimshttps://practicaldermatology.com/news/promius-pharma-employees-fundraise-for-hurricane-victims/2457974/Promius Pharma LLC's employees raised $12,715 to support American Red Cross relief efforts to assist those affected by the recent hurricanes. Additionally, Promius' parent company Dr. Reddy's Laboratories matched this donation for a combined contribution